{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:48:12Z","timestamp":1794984492764,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000368","name":"Brain Research Trust","doi-asserted-by":"publisher","award":["201617-06"],"award-info":[{"award-number":["201617-06"]}],"id":[{"id":"10.13039\/501100000368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000368","name":"Brain Research Trust","doi-asserted-by":"publisher","award":["201617-06"],"award-info":[{"award-number":["201617-06"]}],"id":[{"id":"10.13039\/501100000368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000368","name":"Brain Research Trust","doi-asserted-by":"publisher","award":["201617-06"],"award-info":[{"award-number":["201617-06"]}],"id":[{"id":"10.13039\/501100000368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","award":["ARUK-PPG2018A-015"],"award-info":[{"award-number":["ARUK-PPG2018A-015"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Research UK"},{"name":"Alzheimer's Research UK"},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012068","name":"Health and Care Research Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease is caused by an expanded CAG tract in\n                    <jats:italic>HTT<\/jats:italic>\n                    . The length of the CAG tract accounts for over half the variance in age at onset of disease, and is influenced by other genetic factors, mostly implicating the DNA maintenance machinery. We examined a single nucleotide variant, rs79727797, on chromosome 5 in the\n                    <jats:italic>TCERG1<\/jats:italic>\n                    gene, previously reported to be associated with Huntington\u2019s disease and a quasi-tandem repeat (QTR) hexamer in exon 4 of\n                    <jats:italic>TCERG1<\/jats:italic>\n                    with a central pure repeat. We developed a method for calling perfect and imperfect repeats from exome-sequencing data, and tested association between the QTR in\n                    <jats:italic>TCERG1<\/jats:italic>\n                    and residual age at motor onset (after correcting for the effects of CAG length in the\n                    <jats:italic>HTT<\/jats:italic>\n                    gene) in 610 individuals with Huntington\u2019s disease via regression analysis. We found a significant association between age at onset and the sum of the repeat lengths from both alleles of the QTR (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20092.1 \u00d7 10\n                    <jats:sup>\u22129<\/jats:sup>\n                    ), with each added repeat hexamer reducing age at onset by one year (95% confidence interval [0.7, 1.4]). This association explained that previously observed with rs79727797. The association with age at onset in the genome-wide association study is due to a QTR hexamer in\n                    <jats:italic>TCERG1<\/jats:italic>\n                    , translated to a glutamine\/alanine tract in the protein. We could not distinguish whether this was due to cis-effects of the hexamer repeat on gene expression or of the encoded glutamine\/alanine tract in the protein. These results motivate further study of the mechanisms by which\n                    <jats:italic>TCERG1<\/jats:italic>\n                    modifies onset of HD.\n                  <\/jats:p>","DOI":"10.1038\/s41525-022-00317-w","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:10:55Z","timestamp":1662365455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Huntington\u2019s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-1903","authenticated-orcid":false,"given":"Sergey V.","family":"Lobanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branduff","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-6401","authenticated-orcid":false,"given":"Mia","family":"McDade-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"REGISTRY Investigators of the European Huntington\u2019s disease network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PREDICT-HD Investigators of the Huntington Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7181-9652","authenticated-orcid":false,"given":"Jeffrey D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Ryten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-2131","authenticated-orcid":false,"given":"Thomas H.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-4612","authenticated-orcid":false,"given":"Lesley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"317_CR1","doi-asserted-by":"crossref","unstructured":"McAllister, B. et al. Timing and impact of psychiatric, cognitive, and motor abnormalities in huntington disease. Neurology 96, e2395\u2013e2406.","DOI":"10.1212\/WNL.0000000000011893"},{"key":"317_CR2","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"317_CR3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"J-M Lee","year":"2012","unstructured":"Lee, J.-M. et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78, 690\u2013695 (2012).","journal-title":"Neurology"},{"key":"317_CR4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi, S. J. et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet. Neurol. 12, 637\u2013649 (2013).","journal-title":"Lancet. Neurol."},{"key":"317_CR5","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler, N. S. et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc. Natl. Acad. Sci. USA 101, 3498\u20133503 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"317_CR6","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015)."},{"key":"317_CR7","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178, 887\u2013900.e14 (2019)."},{"key":"317_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","volume":"16","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Identification of genetic variants associated with Huntington\u2019s disease progression: a genome-wide association study. Lancet Neurol 16, 701\u2013711 (2017).","journal-title":"Lancet Neurol"},{"key":"317_CR9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","volume":"98","author":"S Holbert","year":"2001","unstructured":"Holbert, S. et al. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington\u2019s disease pathogenesis. Proc. Natl. Acad. Sci. 98, 1811\u20131816 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"317_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jmg.2006.045153","volume":"44","author":"JM Andresen","year":"2007","unstructured":"Andresen, J. M. et al. Replication of twelve association studies for Huntington\u2019s disease residual age of onset in large Venezuelan kindreds. J. Med. Genet. 44, 44\u201350 (2007).","journal-title":"J. Med. Genet."},{"key":"317_CR11","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1007\/s12035-016-0284-6","volume":"54","author":"JP Mu\u00f1oz-Cobo","year":"2017","unstructured":"Mu\u00f1oz-Cobo, J. P. et al. Transcriptional elongation regulator 1 affects transcription and splicing of genes associated with cellular morphology and cytoskeleton dynamics and is required for neurite outgrowth in neuroblastoma cells and primary neuronal cultures. Mol. Neurobiol. 54, 7808\u20137823 (2017).","journal-title":"Mol. Neurobiol."},{"key":"317_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1261\/rna.052795.115","volume":"22","author":"N S\u00e1nchez-Hern\u00e1ndez","year":"2016","unstructured":"S\u00e1nchez-Hern\u00e1ndez, N. et al. The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing. RNA 22, 571\u2013582 (2016).","journal-title":"RNA"},{"key":"317_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"317_CR14","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1523\/JNEUROSCI.5409-05.2006","volume":"26","author":"M Arango","year":"2006","unstructured":"Arango, M. et al. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci. 26, 4649\u20134659 (2006).","journal-title":"J. Neurosci."},{"key":"317_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41593-022-01033-5","volume":"25","author":"B McAllister","year":"2022","unstructured":"McAllister, B. et al. Exome sequencing of individuals with Huntington\u2019s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nat. Neurosci. 25, 446\u2013457 (2022).","journal-title":"Nat. Neurosci."},{"key":"317_CR16","first-page":"RRN1184","volume":"2","author":"M Orth","year":"2010","unstructured":"Orth, M. et al. Observing Huntington\u2019s disease: the European Huntington\u2019s disease network\u2019s REGISTRY. PLoS Curr. 2, RRN1184 (2010).","journal-title":"PLoS Curr."},{"key":"317_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen, J. S. et al. Preparing for preventive clinical trials: the Predict-HD study. Arch. Neurol. 63, 883\u2013890 (2006).","journal-title":"Arch. Neurol."},{"key":"317_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481\u2013487 (2016).","journal-title":"Nat. Genet."},{"key":"317_CR19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics 45, 580\u2013585 (2013).","journal-title":"Nature Genetics"},{"key":"317_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.aad6469","volume":"359","author":"MJ Gandal","year":"2018","unstructured":"Gandal, M. J. et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359, 693\u2013697 (2018).","journal-title":"Science"},{"key":"317_CR21","first-page":"10","volume":"18","author":"U V\u00f5sa","year":"2018","unstructured":"V\u00f5sa, U. et al. Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis. bioRxiv 18, 10 (2018).","journal-title":"bioRxiv"},{"key":"317_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2013252 (2016).","journal-title":"Nat. Genet."},{"key":"317_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng.3461","volume":"48","author":"M Gymrek","year":"2015","unstructured":"Gymrek, M. et al. Abundant contribution of short tandem repeats to gene expression variation in humans. Nat. Genet. 48, 22\u201329 (2015).","journal-title":"Nat. Genet."},{"key":"317_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/361162","author":"N Mousavi","year":"2018","unstructured":"Mousavi, N., Shleizer-Burko, S. & Gymrek, M. Profiling the genome-wide landscape of tandem repeat expansions. bioRxiv https:\/\/doi.org\/10.1101\/361162 (2018).","journal-title":"bioRxiv"},{"key":"317_CR25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg.2017.115","volume":"19","author":"AJ Hannan","year":"2018","unstructured":"Hannan, A. J. Tandem repeats mediating genetic plasticity in health and disease. Nat. Rev. Genet. 19, 286\u2013298 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"317_CR26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges, A. et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum. Mol. Genet. 15, 965\u2013977 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"317_CR27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder, P. et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat. Neurosci. 19, 623\u2013633 (2016).","journal-title":"Nat. Neurosci."},{"key":"317_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.64984","volume":"10","author":"L Megret","year":"2021","unstructured":"Megret, L. et al. Shape deformation analysis reveals the temporal dynamics of cell-type-specific homeostatic and pathogenic responses to mutant huntingtin. Elife 10, 1\u201325 (2021).","journal-title":"Elife"},{"key":"317_CR29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jcb.25309","volume":"117","author":"NJ Miller","year":"2016","unstructured":"Miller, N. J., Schick, K., Timchenko, N., Harrison, E. & Roesler, W. J. The glutamine-alanine repeat domain of TCERG1 is required for the inhibition of the growth arrest activity of C\/EBP\u03b1. J. Cell. Biochem. 117, 612\u2013620 (2016).","journal-title":"J. Cell. Biochem."},{"key":"317_CR30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s13311-019-00768-7","volume":"16","author":"T Maiuri","year":"2019","unstructured":"Maiuri, T. et al. DNA damage repair in huntington\u2019s disease and other neurodegenerative diseases. Neurotherapeutics 16, 948\u2013956 (2019).","journal-title":"Neurotherapeutics"},{"key":"317_CR31","doi-asserted-by":"crossref","first-page":"dmm031930","DOI":"10.1242\/dmm.031930","volume":"11","author":"TH Massey","year":"2018","unstructured":"Massey, T. H. & Jones, L. The central role of DNA damage and repair in CAG repeat diseases. Dis. Model. Mech 11, dmm031930 (2018).","journal-title":"Dis. Model. Mech"},{"key":"317_CR32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ajhg.2019.08.003","volume":"105","author":"JA Watts","year":"2019","unstructured":"Watts, J. A. et al. cis elements that mediate RNA polymerase II pausing regulate human gene expression. Am. J. Hum. Genet. 105, 677\u2013688 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"317_CR33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.molcel.2010.11.005","volume":"40","author":"RD Alexander","year":"2010","unstructured":"Alexander, R. D., Innocente, S. A., Barrass, J. D. & Beggs, J. D. Splicing-dependent RNA polymerase pausing in yeast. Mol. Cell 40, 582\u2013593 (2010).","journal-title":"Mol. Cell"},{"key":"317_CR34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.molcel.2010.11.004","volume":"40","author":"F Carrillo Oesterreich","year":"2010","unstructured":"Carrillo Oesterreich, F., Preibisch, S. & Neugebauer, K. M. Global analysis of nascent rna reveals transcriptional pausing in terminal exons. Mol. Cell 40, 571\u2013581 (2010).","journal-title":"Mol. Cell"},{"key":"317_CR35","doi-asserted-by":"crossref","unstructured":"Wilhelm, B. T. et al. Differential patterns of intronic and exonic DNA regions with respect to RNA polymerase II occupancy, nucleosome density and H3K36me3 marking in fission yeast. Genome Biol. 12, R82 (2011).","DOI":"10.1186\/gb-2011-12-8-r82"},{"key":"317_CR36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1073\/pnas.0909740107","volume":"107","author":"Y Lin","year":"2010","unstructured":"Lin, Y., Dent, S. Y. R., Wilson, J. H., Wells, R. D. & Napierala, M. R loops stimulate genetic instability of CTG\u00b7CAG repeats. Proc. Natl. Acad. Sci. U.S.A. 107, 692\u2013697 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"317_CR37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00294-018-0806-z","volume":"64","author":"CH Freudenreich","year":"2018","unstructured":"Freudenreich, C. H. R-loops: targets for nuclease cleavage and repeat instability. Curr. Genet. 64, 789\u2013794 (2018).","journal-title":"Curr. Genet."},{"key":"317_CR38","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1074\/jbc.REV119.007678","volume":"295","author":"AN Khristich","year":"2020","unstructured":"Khristich, A. N. & Mirkin, S. M. On the wrong DNA track: molecular mechanisms of repeat-mediated genome instability. J. Biol. Chem. 295, 4134\u20134170 (2020).","journal-title":"J. Biol. Chem."},{"key":"317_CR39","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder, A. et al. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci. Rep. 7, 1307 (2017).","journal-title":"Sci. Rep."},{"key":"317_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06281-3","volume":"9","author":"A Neueder","year":"2018","unstructured":"Neueder, A., Dumas, A. A., Benjamin, A. C. & Bates, G. P. Regulatory mechanisms of incomplete huntingtin mRNA splicing. Nat. Commun. 9, 3955 (2018).","journal-title":"Nat. Commun."},{"key":"317_CR41","doi-asserted-by":"crossref","first-page":"e1003930","DOI":"10.1371\/journal.pgen.1003930","volume":"9","author":"RM Pinto","year":"2013","unstructured":"Pinto, R. M. et al. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet 9, e1003930 (2013).","journal-title":"PLoS Genet"},{"key":"317_CR42","doi-asserted-by":"crossref","first-page":"e1007719","DOI":"10.1371\/journal.pgen.1007719","volume":"14","author":"X Zhao","year":"2018","unstructured":"Zhao, X., Zhang, Y., Wilkins, K., Edelmann, W. & Usdin, K. MutL\u03b3 promotes repeat expansion in a Fragile X mouse model while EXO1 is protective. PLOS Genet. 14, e1007719 (2018).","journal-title":"PLOS Genet."},{"key":"317_CR43","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1093\/nar\/gky099","volume":"46","author":"AJ Neil","year":"2018","unstructured":"Neil, A. J., Liang, M. U., Khristich, A. N., Shah, K. A. & Mirkin, S. M. RNA-DNA hybrids promote the expansion of Friedreich\u2019s ataxia (GAA)n repeats via break-induced replication. Nucleic Acids Res. 46, 3487\u20133497 (2018).","journal-title":"Nucleic Acids Res."},{"key":"317_CR44","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","volume":"26","author":"J-M Lee","year":"2017","unstructured":"Lee, J.-M. et al. A modifier of Huntington\u2019s disease onset at the MLH1 locus. Hum. Mol. Genet. 26, 3859\u20133867 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"317_CR45","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1074\/jbc.M709402200","volume":"283","author":"JL Pearson","year":"2008","unstructured":"Pearson, J. L., Robinson, T. J., Mu\u00f1oz, M. J., Kornblihtt, A. R. & Garcia-Blanco, M. A. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. J. Biol. Chem. 283, 7949\u20137961 (2008).","journal-title":"J. Biol. Chem."},{"key":"317_CR46","doi-asserted-by":"crossref","first-page":"jcs232728","DOI":"10.1242\/jcs.232728","volume":"132","author":"C Moreno-Castro","year":"2019","unstructured":"Moreno-Castro, C. et al. Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly. J. Cell Sci. 132, jcs232728 (2019).","journal-title":"J. Cell Sci."},{"key":"317_CR47","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1073\/pnas.1421313111","volume":"111","author":"L Ripaud","year":"2014","unstructured":"Ripaud, L. et al. Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome. Proc. Natl. Acad. Sci. USA 111, 18219\u201318224 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"317_CR48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-018-0639-5","volume":"6","author":"M Pons","year":"2018","unstructured":"Pons, M. et al. Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila. Acta Neuropathol. Commun. 6, 138 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"317_CR49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab, C., Arai, T., Hasegawa, M., Yu, S. & McGeer, P. L. Colocalization of transactivation-responsive DNA-binding protein 43 and Huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 67, 1159\u20131165 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"317_CR50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen, J. S. et al. Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatry 79, 874\u2013880 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"317_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/protex.2018.089","author":"M Ciosi","year":"2018","unstructured":"Ciosi, M. et al. Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism. Protoc. Exch. https:\/\/doi.org\/10.1038\/protex.2018.089 (2018).","journal-title":"Protoc. Exch."},{"key":"317_CR52","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"317_CR53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn, D. R. et al. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin. Genet. 65, 267\u2013277 (2004).","journal-title":"Clin. Genet."},{"key":"317_CR54","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-022-00317-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-022-00317-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-022-00317-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T08:34:46Z","timestamp":1664958886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-022-00317-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1038\/s41525-022-00317-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.16.452643","asserted-by":"object"}]},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.F.G.: Scientific Advisory Board member and has a financial interest in Triplet Therapeutics, Inc. His NIH-funded project is using genetic and genomic approaches to uncover other genes that significantly influence when diagnosable symptoms emerge and how rapidly they worsen in Huntington disease. The company is developing new therapeutic approaches to address triplet repeat disorders such Huntington\u2019s disease, myotonic dystrophy and spinocerebellar ataxias. His interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. G.B.L.: Consulting services, advisory board functions, clinical trial services and\/or lectures for Allergan, Alnylam, Amarin, AOP Orphan Pharmaceuticals AG, Bayer Pharma AG, CHDI Foundation, GlaxoSmithKline, Hoffmann-LaRoche, Ipsen, ISIS Pharma, Lundbeck, Neurosearch Inc, Medesis, Medivation, Medtronic, NeuraMetrix, Novartis, Pfizer, Prana Biotechnology, Sangamo\/Shire, Siena Biotech, Temmler Pharma GmbH and Teva Pharmaceuticals. He has received research grant support from the CHDI Foundation, the Bundesministerium f\u00fcr Bildung und Forschung (BMBF), the Deutsche Forschungsgemeinschaft (DFG), the European Commission (EU-FP7, JPND). His study site Ulm has received compensation in the context of the observational Enroll-HD Study, TEVA, ISIS and Hoffmann-Roche and the Gossweiler Foundation. He receives royalties from the Oxford University Press and is employed by the State of Baden-W\u00fcrttemberg at the University of Ulm. A.E.R.: Chair of European Huntington\u2019s Disease Network (EHDN) executive committee, Global PI for Triplet Therapeutics L.J. is a member of the scientific advisory boards of LoQus23 Therapeutics and Triplet Therapeutics. T.H.M. is an associate member of the scientific advisory board of LoQus23 Therapeutics. J-M.L is a member of the Scientific Advisory Board of GenEdit, Inc., J.D.L is a paid board member for F. Hoffmann-La Roche Ltd and uniQure biopharma B.V., and he is a paid consultant for Vaccinex Inc, Wave Life Sciences USA Inc, Genentech Inc, Triplet Therapeutics Inc, PTC Therapeutics Inc, and Remix Therapeutics. S.L., B.Mc., J-M.L., M.E.M., M.R., N.M.W., M.O. and P.H.: nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}